Skip to main content
ABSI logo

Absci Corporation

ABSINASDAQHealthcareBiotechnology

$8.88Today:- (-)1Y +82.34%

As of Oct 15, 2026 close

Market cap
$1.40B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.24$12.06
Volume (live)
-
Avg. volume (3M)
4.00M

Absci (ABSI) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Absci used $92.92M of cash in operating activities and spent $1.11M on capital expenditures. That left free cash flow of −$94.03M.

Absci Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Absci Corporation (ABSI) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-115.18-103.11-110.57-104.90-100.96-14.35-6.58
Depreciation & Amortization11.7413.3914.0013.046.651.130.49
Deferred Income Tax0.000.00-0.05-0.51-8.900.000.00
Stock Based Compensation18.3219.4511.4212.5410.610.420.04
Change in Working Capital0.42-0.371.52-1.54-3.151.01-0.09
Change in Accounts Receivable0.002.24-0.67-0.150.23-1.37-0.10
Change in Accounts Payable1.092.03-0.79-0.531.570.900.08
Change in Other Working Capital-5.69-4.632.971.76-4.25-0.37-0.07
Other Operating Activities-5.69-1.7719.05-0.4726.250.460.11
Net Cash from Operating Activities-92.93-72.40-64.64-81.34-60.60-10.97-6.03
Investing Activities
Capital Expenditures-1.11-0.40-0.86-16.18-38.05-2.18-1.10
Acquisitions1.310.000.00-8.00-28.130.000.00
Purchases of Investments-119.87-186.11-147.35-108.59-1.200.000.00
Sales/Maturities of Investments69.50144.00229.905.000.000.000.00
Other Investing Activities0.000.940.250.650.000.010.01
Net Cash from Investing Activities-50.16-41.5881.94-126.98-67.38-2.17-1.09
Financing Activities
Debt Repayment-3.20-4.03-5.35-4.65-1.601.642.38
Common Stock Issued105.8486.560.860.66210.400.000.00
Other Financing Activities0.000.000.00-2.80-19.9069.3310.33
Net Cash from Financing Activities105.9582.53-4.485.24336.1970.9712.71
Summary
Net Change in Cash-37.14-31.4512.83-203.08208.2257.835.59
Cash at Beginning of Period58.2189.6776.84279.9371.7113.888.29
Cash at End of Period21.0858.2189.6776.84279.9371.7113.88
Free Cash Flow-94.03-72.81-65.50-97.51-98.65-13.15-7.13
Supplemental Disclosures
Interest Paid-0.560.970.900.650.51-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Absci Cash Flow

What is Absci's free cash flow?

Absci had negative free cash flow of $94.03M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$92.92M minus $1.11M of capital expenditures.

How much does Absci spend on capital expenditures?

Absci spent $1.11M on capital expenditures in fiscal 2025, compared with $404.00K a year earlier.

Does Absci pay dividends or buy back shares?

Absci's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition